William Pao
Director/Board Member at Transcelerate Biopharma, Inc.
Net worth: 2 M $ as of 30/04/2024
William Pao active positions
| Companies | Position | Start | End |
|---|---|---|---|
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Director/Board Member | - | - |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Director/Board Member | - | - |
Career history of William Pao
Former positions of William Pao
| Companies | Position | Start | End |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 21/03/2022 | 15/08/2023 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/05/2014 | 18/03/2022 |
| My Cancer Genome | Founder | - | - |
The Vanderbilt-Ingram Cancer Center
 The Vanderbilt-Ingram Cancer Center Hospital/Nursing ManagementHealth Services The Vanderbilt-Ingram Cancer Center engages in the prevention, diagnosis, and treatment of cancer. The non-profit company is based in Nashville, TN. | Corporate Officer/Principal | - | - |
| Vanderbilt University | Corporate Officer/Principal | - | - |
Training of William Pao
| Harvard University | Undergraduate Degree |
| Yale University | Doctorate Degree |
Statistics
International
| United States | 9 |
| Switzerland | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ROCHE HOLDING AG | Health Technology |
| Private companies | 4 |
|---|---|
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
The Vanderbilt-Ingram Cancer Center
The Vanderbilt-Ingram Cancer Center Hospital/Nursing ManagementHealth Services The Vanderbilt-Ingram Cancer Center engages in the prevention, diagnosis, and treatment of cancer. The non-profit company is based in Nashville, TN. | Health Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
| My Cancer Genome |
- Stock Market
- Insiders
- William Pao
- Experience
